We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

23 hedge funds and large institutions have $25.4M invested in Tenax Therapeutics in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

5% more funds holding

Funds holding: 22 → 23 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

36% less capital invested

Capital invested by funds: $40.1M → $25.4M (-$14.6M)

Holders
23
Holders Change
+1
Holders Change %
+4.55%
% of All Funds
0.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
2
Reduced
1
Closed
1
Calls
$35K
Puts
–
Net Calls
+$35K
Net Calls Change
+$35K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$466K
2
SM
Sabby Management
Florida
+$233K
3
SC
Scotia Capital
Ontario, Canada
+$233K
4
CS
Credit Suisse
Switzerland
+$77.7K

Top Sellers

Rank Fund Capital Flow
1
B
Bailard
California
-$197K
2
OM
Opaleye Management
Massachusetts
-$77.7K
3
IA
IFP Advisors
Florida
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$5.68M +$233K +3 +4%
RCM
2
RA Capital Management
Massachusetts
$4.9M – – –
BC
3
Broadfin Capital
New York
$4.04M – – –
AC
4
Armistice Capital
New York
$2.4M +$466K +6 +19%
GPP
5
Great Point Partners
Connecticut
$2.27M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$2.02M – – –
OM
7
Opaleye Management
Massachusetts
$1.02M -$77.7K -1 -6%
BBA
8
Baker Bros. Advisors
New York
$861K – – –
CA
9
Commerzbank Aktiengesellschaft
Germany
$615K – – –
Bank of New York Mellon
10
Bank of New York Mellon
New York
$265K – – –
SC
11
Scotia Capital
Ontario, Canada
$218K +$233K +3 New
Deutsche Bank
12
Deutsche Bank
Germany
$190K – – –
DCM
13
DAFNA Capital Management
California
$163K – – –
BFA
14
BlackRock Fund Advisors
California
$127K – – –
NFA
15
Nationwide Fund Advisors
Ohio
$123K – – –
BCM
16
Bourgeon Capital Management
Connecticut
$114K – – –
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$82K – – –
Verition Fund Management
18
Verition Fund Management
Connecticut
$66K – – –
BIT
19
BlackRock Institutional Trust
California
$65K – – –
Northern Trust
20
Northern Trust
Illinois
$61K – – –
Goldman Sachs
21
Goldman Sachs
New York
$54K – – –
CS
22
Credit Suisse
Switzerland
$39K +$77.7K +1 New
Citadel Advisors
23
Citadel Advisors
Florida
$30K – – –
VKH
24
Virtu KCG Holdings
New York
$21K – – –
BIM
25
BlackRock Investment Management
Delaware
$8K – – –
1
2

TENX Hedge Fund Activity: Q1 2016 in Review

23 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q1 2016, worth a combined $25.4M — down 36% from $40.1M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new TENX positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Armistice Capital, adding an estimated $466K. The largest seller was Bailard, exiting entirely with an estimated $197K sold.

  • 23 institutional investors held Tenax Therapeutics (TENX) as of Q1 2016, up from 22 in Q4 2015.
  • Funds reported $25.4M of Tenax Therapeutics stock for Q1 2016, down 36% quarter-over-quarter.
  • 2 funds opened new Tenax Therapeutics positions in Q1 2016 and 1 closed out, a net change of +1 holder.
  • The largest Tenax Therapeutics buyer in Q1 2016 was Armistice Capital, an estimated $466K added.
  • The largest Tenax Therapeutics seller in Q1 2016 was Bailard, an estimated $197K sold.

Based on aggregated 13F filings for Q1 2016.